XERS logo

Xeris Biopharma Holdings (XERS) Shareholders Equity

Annual Shareholders Equity

-$6.78 M
-$51.97 M-115.01%

31 December 2023

XERS Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

-$28.32 M
-$9.04 M-46.86%

30 September 2024

XERS Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

XERS Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-115.0%-832.8%
3 y3 years-120.1%-1050.9%
5 y5 years-109.0%-164.9%

XERS Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-107.1%at low-129.4%at low
5 y5 years-107.1%at low-129.4%at low
alltimeall time-107.1%+88.3%-125.9%+51.0%

Xeris Biopharma Holdings Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
-$28.32 M(+46.9%)
June 2024
-
-$19.29 M(+110.1%)
Mar 2024
-
-$9.18 M(+35.3%)
Dec 2023
-$6.78 M(-115.0%)
-$6.78 M(-275.5%)
Sept 2023
-
$3.87 M(-71.7%)
June 2023
-
$13.64 M(-54.6%)
Mar 2023
-
$30.05 M(-33.5%)
Dec 2022
$45.19 M(-52.6%)
$45.19 M(-17.9%)
Sept 2022
-
$55.04 M(-25.6%)
June 2022
-
$73.94 M(-23.3%)
Mar 2022
-
$96.45 M(+1.3%)
Dec 2021
$95.23 M
$95.23 M(-3969.6%)
Sept 2021
-
-$2.46 M(-112.4%)
June 2021
-
$19.89 M(-55.2%)
DateAnnualQuarterly
Mar 2021
-
$44.39 M(+31.5%)
Dec 2020
$33.76 M(+133.9%)
$33.76 M(+135.5%)
Sept 2020
-
$14.34 M(-41.2%)
June 2020
-
$24.38 M(-9.9%)
Mar 2020
-
$27.07 M(+87.5%)
Dec 2019
$14.44 M(-80.9%)
$14.44 M(-66.9%)
Sept 2019
-
$43.66 M(-41.6%)
June 2019
-
$74.79 M(-30.2%)
Mar 2019
-
$107.10 M(+42.0%)
Dec 2018
$75.41 M(-230.4%)
$75.41 M(-20.7%)
Sept 2018
-
$95.12 M(-13.0%)
June 2018
-
$109.34 M(+232.8%)
Mar 2018
-
$32.85 M(-156.8%)
Dec 2017
-$57.83 M(+81.1%)
-$57.83 M
Dec 2016
-$31.93 M
-

FAQ

  • What is Xeris Biopharma Holdings annual stockholders equity?
  • What is the all time high annual shareholders equity for Xeris Biopharma Holdings?
  • What is Xeris Biopharma Holdings annual shareholders equity year-on-year change?
  • What is Xeris Biopharma Holdings quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Xeris Biopharma Holdings?
  • What is Xeris Biopharma Holdings quarterly shareholders equity year-on-year change?

What is Xeris Biopharma Holdings annual stockholders equity?

The current annual shareholders equity of XERS is -$6.78 M

What is the all time high annual shareholders equity for Xeris Biopharma Holdings?

Xeris Biopharma Holdings all-time high annual stockholders equity is $95.23 M

What is Xeris Biopharma Holdings annual shareholders equity year-on-year change?

Over the past year, XERS annual stockholders equity has changed by -$51.97 M (-115.01%)

What is Xeris Biopharma Holdings quarterly stockholders equity?

The current quarterly shareholders equity of XERS is -$28.32 M

What is the all time high quarterly shareholders equity for Xeris Biopharma Holdings?

Xeris Biopharma Holdings all-time high quarterly stockholders equity is $109.34 M

What is Xeris Biopharma Holdings quarterly shareholders equity year-on-year change?

Over the past year, XERS quarterly stockholders equity has changed by -$32.19 M (-832.81%)